Alirocumab
|
1
|
Resverlogix Corp.
|
Apr 13, 2020 04:33PM
|
Icosapent Ethyl
|
1
|
Resverlogix Corp.
|
Apr 13, 2020 04:42PM
|
Two Interesting Articles: - 1 of 2 Developing Covid-19 Vaccines at Pandemic Speed
|
1
|
Resverlogix Corp.
|
Apr 13, 2020 04:54PM
|
Two Interesting Articles - 2 of 2: COVID-19: consider cytokine storm syndromes and immunosuppression
|
4
|
Resverlogix Corp.
|
Apr 13, 2020 05:01PM
|
Re: Two Interesting Articles - 2 of 2: COVID-19: consider cytokine storm syndromes and immunosuppression
|
6
|
Resverlogix Corp.
|
Apr 13, 2020 08:03PM
|
Re: Two Interesting Articles - 2 of 2: COVID-19: consider cytokine storm syndromes and immunosuppression
|
2
|
Resverlogix Corp.
|
Apr 14, 2020 11:18PM
|
Re: Two Interesting Articles - 2 of 2: COVID-19: consider cytokine storm syndromes and immunosuppression
|
3
|
Resverlogix Corp.
|
Apr 21, 2020 08:07PM
|
60/160 Treatments in Development for CoronaVirus - Did not see Apabetalone in Quick Scan
|
1
|
Resverlogix Corp.
|
Apr 25, 2020 12:05AM
|
Re: 60/160 Treatments in Development for CoronaVirus - Did not see Apabetalone in Quick Scan
|
2
|
Resverlogix Corp.
|
Apr 25, 2020 12:15AM
|
Article - COVID-19 Lung Problems May Start in Blood Vessels
|
8
|
Resverlogix Corp.
|
Apr 27, 2020 07:39PM
|
Re: Article - COVID-19 Lung Problems May Start in Blood Vessels
|
4
|
Resverlogix Corp.
|
Apr 27, 2020 09:53PM
|
Re: Article - COVID-19 Lung Problems May Start in Blood Vessels
|
3
|
Resverlogix Corp.
|
Apr 27, 2020 10:39PM
|
Re: Article - COVID-19 Lung Problems May Start in Blood Vessels
|
3
|
Resverlogix Corp.
|
Apr 27, 2020 10:39PM
|
Re: C19
|
2
|
Resverlogix Corp.
|
May 13, 2020 08:51AM
|
Re: Apabetalone - BET protein inhibition in cardiovascular disease and Type 2 diabetes
|
10
|
Resverlogix Corp.
|
May 13, 2020 09:12AM
|
Apabetalone recudes ALP (apologies if repeat. looked on the new side)
|
5
|
Resverlogix Corp.
|
Jun 10, 2020 11:21PM
|
Re: Apabetalone recudes ALP (apologies if repeat. looked on the new side)
|
2
|
Resverlogix Corp.
|
Jun 11, 2020 12:54AM
|
Rough Transcript - Resverlogix Corporate Update and Conference Call - 06/10/2020
|
9
|
Resverlogix Corp.
|
Jun 11, 2020 12:57AM
|
Re: BOM 2 Trial
|
9
|
Resverlogix Corp.
|
Jun 11, 2020 01:15AM
|
Re: Apabetalone recudes ALP (apologies if repeat. looked on the new side)
|
1
|
Resverlogix Corp.
|
Jun 11, 2020 06:13PM
|